Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 18;56(5):860-867.
doi: 10.19723/j.issn.1671-167X.2024.05.017.

[Immunomodulatory mechanism of umbilical cord mesenchymal stem cells modified by miR-125b-5p in systemic lupus erythematosus]

[Article in Chinese]
Affiliations

[Immunomodulatory mechanism of umbilical cord mesenchymal stem cells modified by miR-125b-5p in systemic lupus erythematosus]

[Article in Chinese]
Zhihui Wu et al. Beijing Da Xue Xue Bao Yi Xue Ban. .

Abstract

Objective: To investigate the mechanism of immunomodulatory effects of umbilical cord mesenchymal stem cells (UC-MSCs) modified by miR-125b-5p on systemic lupus erythematosus (SLE).

Methods: The expression level of miR-125b-5p was detected by real-time fluorescence quantitative PCR in UC-MSCs and peripheral blood mononuclear cells (PBMCs) from SLE patients and health checkers. Annexin V-FITC/PI apoptosis detection kit was used to detect the effect of miR-125b-5p on apoptosis of UC-MSCs. MRL/lpr mice in each group were injected with UC-MSCs via tail vein, and T-lymphocyte subsets in the spleen of the MRL/lpr mice were detected by flow cytometry after 5 weeks. The expression levels of interleukin (IL)-4 and IL-17A in serum of MRL/lpr mice were detected by ELISA. Hematoxylin-eosin staining was used to observe the pathological manifestations of the lungs and kidneys of the MRL/lpr mice.

Results: miR-125b-5p was significantly down-regulated in PBMCs of SLE patients compared with healthy controls (P < 0.01). Compared with the UC-MSCs group, the expression of miR- 125b-5p in UC-MSCs modified by miR-125b-5p group was increased (P < 0.01). The survival rate of UC-MSCs was significantly increased by miR-125b-5p (P < 0.01). Compared with the untreated group of MRL/lpr mice, the expression level of IL-4 in serum was increased (P < 0.05); the expression level of IL-17A was decreased (P < 0.05); the proportion of Th17 cells in the spleen of MRL/lpr mice was decreased (P < 0.05); the inflammatory cells infiltration and micro-thrombosis of lungs and kidneys of MRL/lpr mice were significantly reduced in the UC-MSCs modified by miR-125b-5p treatment group.

Conclusion: UC-MSCs modified by miR-125b-5p have immunomodulatory effects on systemic lupus erythematosus.

目的: 研究miR-125b-5p修饰脐带间充质干细胞(umbilical cord mesenchymal stem cells,UC-MSCs)对系统性红斑狼疮(systemic lupus erythematosus,SLE)的免疫调控作用机制。

方法: 实时荧光定量PCR检测miR-125b-5p在UC-MSCs和SLE患者、健康体检者外周血单个核细胞中的表达水平;Annexin V-FITC/PI凋亡检测试剂盒检测miR-125b-5p对UC-MSCs的凋亡影响;每周对MRL/lpr小鼠进行尾静脉注射UC-MSCs,5周后流式细胞术检测各组小鼠脾细胞T淋巴细胞亚群分化情况;ELISA法检测各组MRL/lpr小鼠血清中白细胞介素(interleukin,IL)-4和IL-17A表达水平;苏木精-伊红染色法观察MRL/lpr小鼠肺和肾组织病理变化。

结果: 与健康对照组相比,SLE患者外周血单个核细胞中miR-125b-5p的表达水平显著下调(P < 0.01);与UC-MSCs相比,miR-125b-5p转染UC-MSCs组miR-125b-5p的表达水平显著上调(P < 0.01)。miR-125b-5p转染UC-MSCs 48 h可显著提高细胞存活率(P < 0.01);与未处理的MRL/lpr小鼠组相比,miR-125b-5p修饰UC-MSCs对MRL/lpr小鼠脾脏Th17细胞分化具有明显的下调作用(P < 0.05),且在小鼠血清中IL-4表达水平明显升高(P < 0.05),IL-17A表达水平明显减低(P < 0.05)。经miR-125b-5p修饰的UC-MSCs治疗后,MRL/lpr小鼠肺和肾组织内炎性细胞浸润和微血栓减少。

结论: miR-125b-5p修饰UC-MSCs对SLE具有免疫调控作用。

Keywords: Gene modification; Immunomo-dulation; Mesenchymal stem cells; Systemic lupus erythematosus; Umbilical cord.

PubMed Disclaimer

Conflict of interest statement

利益冲突 所有作者均声明不存在利益冲突。

Figures

图 1
图 1
健康对照和SLE患者PBMCs中miR-125b-5p的表达水平(n=19) miR-125b-5p expression in PBMCs from health control and SLE (n=19)
图 2
图 2
miR-125b-5p在转染后的UC-MSCs中的表达(n=3) Expression of miR-125b-5p in transfected UC-MSCs (n=3)
图 3
图 3
各组UC-MSCs凋亡率 Apoptosis rate of UC-MSCs in each group
图 4
图 4
MRL/lpr小鼠脾细胞Th17、Treg、Th1、Th2细胞流式检测图 Flow cytometry analysis of Th17, Treg, Th1, Th2 cells in MRL/lpr mouse spleen cells
图 5
图 5
各组MRL/lpr小鼠脾细胞T细胞亚群分化情况(n=4) Differentiation of T cell subsets in spleen cells of MRL/lpr mice in each group (n=4)
图 6
图 6
各组MRL/lpr小鼠肺组织及肾组织病理形态(HE ×22.9) Pathological morphology of lung and kidney tissues in MRL/lpr mice in each group (HE ×22.9)

Similar articles

Cited by

References

    1. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365(22):2110–2121. doi: 10.1056/NEJMra1100359. - DOI - PubMed
    1. Relle M, Foehr B, Schwarting A. Epigenetic aspects of systemic lupus erythematosus. Rheumatol Ther. 2015;2(1):33–46. doi: 10.1007/s40744-015-0014-y. - DOI - PMC - PubMed
    1. Basta F, Fasola F, Triantafyllias K, et al. Systemic lupus erythematosus (SLE) therapy: The old and the new. Rheumatol Ther. 2020;7(3):433–446. doi: 10.1007/s40744-020-00212-9. - DOI - PMC - PubMed
    1. Sharabi A, Tsokos GC. T cell metabolism: New insights in systemic lupus erythematosus pathogenesis and therapy. Nat Rev Rheumatol. 2020;16(2):100–112. doi: 10.1038/s41584-019-0356-x. - DOI - PubMed
    1. Muhammad Yusoff F, Wong KK, Mohd Redzwan N. Th1, Th2, and Th17 cytokines in systemic lupus erythematosus. Autoimmunity. 2020;53(1):8–20. doi: 10.1080/08916934.2019.1693545. - DOI - PubMed

Publication types